Summary information for this document is not currently available.
Download as PDF
PDF files are made available as a convenience. In cases where the EUDA is not the originator of the document, please be aware that any PDFs available on this page may not be authoritative or there may be more recent versions available. While we make every effort to ensure that these files are definitive, before using or citing them, we recommend that you consult the publisher's website or contact the author(s) to check for more recent versions.
Abstract
Background
Hexahydrocannabinol (HHC) is a semi-synthetic cannabinoid which was marketed and sold openly in Ireland as a legal alternative to cannabis products until it was controlled in July 2025. There have been reports of psychotic illness precipitated by HHC use. Consequently, there are fears that HHC may become a public health issue. This study’s aim was to measure the extent of HHC use and patterns of use among adults in Ireland who use drugs.
Methods
Data on HHC use in Ireland were collected from participants aged 18+ years (N = 2314) who had used drugs in the previous year via the 2024 European Web Survey on Drugs, which included questions on frequency of use; reasons for starting and using; how HHC was obtained and administration method; and harms arising from use.
Results
In total, 36.2 % reported lifetime HHC use, 33.5 % last-year use, and 17.8 % last-month use. The primary motive for first using HHC was its easy availability in stores and the main source of HHC reported was a high street shop (62.4 %). Negative consequences arising from HHC use were reported by 89.9 % of respondents: 14.7 % reported anxiety or panic reactions, while 13.4 % felt faint or dizzy and 11.9 % reported dissociation or depersonalisation. Hallucinations or psychosis were reported by 3.9 %, depression by 3.6 %, and withdrawal symptoms by 3.2 %.
Conclusions
These data suggest that HHC has become a prominent feature of the Irish drug landscape. Given its harm potential, it will be important to monitor HHC use and related health harms.
- Open access
- English